New England Journal of Medicine · 2010 · 249 citations · 2 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyAsthma ManagementAsthma PharmacotherapyBronchodilator TherapyClinical TrialsInhaled Medication AdministrationRegulatory PharmacologyBeta2-adrenergic Agonist TherapyLaba CombinationsLong-acting Beta AgonistsLong-acting Beta2-agonistsLong-acting Bronchodilator TherapySafety Of Asthma Medications
The FDA has conducted a comprehensive review of the benefits and risks of using LABAs to treat asthma. Drs. Badrul Chowdhury and Gerald Dal Pan discuss the agency's conclusions.
2